Immunology/Inflammation(免疫及炎症)
The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.
Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].
BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].
Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.
Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].
References
[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.
[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.
[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.
[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.
[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.
[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.
[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.
[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.
Products for Immunology/Inflammation
- 5-Lipoxygenase(10)
- Papain(1)
- PGDS(1)
- PGE synthase(24)
- SIKs(10)
- IκB/IKK(63)
- AP-1(3)
- KEAP1-Nrf2(63)
- NOD1(1)
- TLR(125)
- NF-κB(226)
- Interleukin Related(144)
- 15-lipoxygenase(2)
- Others(63)
- Aryl Hydrocarbon Receptor(32)
- CD73(14)
- Complement System(51)
- Galectin(10)
- IFNAR(21)
- NO Synthase(73)
- NOD-like Receptor (NLR)(45)
- STING(97)
- Reactive Oxygen Species(436)
- Apoptosis(631)
- FKBP(19)
- eNOS(5)
- iNOS(28)
- nNOS(20)
- Glutathione(52)
- Adaptive Immunity(206)
- Allergy(125)
- Arthritis(32)
- Autoimmunity(175)
- Gastric Disease(91)
- Immunosuppressants(36)
- Immunotherapeutics(4)
- Innate Immunity(552)
- Pulmonary Diseases(110)
- Reactive Nitrogen Species(49)
- Reactive Sulfur Species(26)
- Specialized Pro-Resolving Mediators(50)
- Cyclic GMP-AMP Synthase(2)
- Cat.No. 产品名称 Information
-
GC39623
DCC-3014
DCC-3014
Vimseltinib (DCC-3014) is a c-FMS (CSF-IR) and c-Kit dual inhibitor extracted from patent WO2014145025A2, Compound Example 10, has IC50s of <0.01 μM and 0.1-1 μM, respectively. -
GC39603
Methylene blue trihydrate
亚甲蓝三水合物; C.I. Basic Blue 9 trihydrate
Methylene blue trihydrate (C.I. Basic Blue 9 trihydrate) 是一种鸟苷酸环化酶 (sGC),单胺氧化酶 A (MAO-A) 和 NO 合酶 (NOS) 抑制剂。Methylene blue trihydrate 是一种血管加压药,在医疗中通常用作染料。Methylene blue trihydrate 具有抗伤害感受,抗疟疾,抗抑郁和抗焦虑作用,可用于高铁血红蛋白血症,神经退行性疾病和异环磷酰胺引起的脑病的研究。 -
GC39600
Iron sucrose
蔗糖铁; Iron saccharate
Iron sucrose (Iron saccharate, Sucroferric oxyhydroxide) is an intravenously administered iron product indicated in the treatment of iron deficiency anemia. -
GC39584
AGN194204
IRX4204; NRX194204; VTP 194204
AGN194204 (IRX4204) 是一种具有口服活性的,选择性 RXR 激动剂,对 RXRα,RXRβ 和 RXRγ 的 Kd 值分别为 0.4 nM,3.6 nM 和 3.8 nM,EC50 分别为 0.2 nM,0.8 nM 和 0.08 nM。AGN194204 对 RAR 无活性,并具有抗炎和抗癌作用。 -
GC39564
Vamorolone
地塞米松EP杂质E,VBP15
Vamorolone (VBP15) 是首创的,具有口服活性的解离性类固醇 (dissociative steroidal) 抗炎药和膜稳定剂。Vamorolone 改善肌营养不良,无副作用。Vamorolone 抑制 (NF-κB) 抑制作用,并降低了激素的影响。 - GC39556 CDDO-3P-Im CDDO-3P-Im 是 CDDO 咪唑胺类似物,具有化学预防作用。CDDO-3P-Im 可降低小鼠肺癌模型肺肿瘤的大小和严重程度。
- GC39555 CDDO-2P-Im CDDO-2P-Im 是 CDDO 咪唑胺类似物,具有化学预防作用。CDDO-2P-Im 可降低小鼠肺癌模型肺肿瘤的大小和严重程度。
-
GC39554
AT2 receptor agonist C21
AT2 receptor agonist C21
An AT2 receptor agonist - GC39551 BRD3308 An HDAC3 inhibitor
- GC39515 TP508 TFA TP508 TFA 是一种 23 个氨基酸的非蛋白水解凝血酶肽,代表凝血酶分子受体结合结构域的一部分。TP508 TFA 可激活内皮 NO synthase (eNOS) 并刺激人内皮细胞中 NO 的产生。TP508 TFA 通过激活内皮细胞和干细胞以使血管再生和组织再生。
-
GC39512
Tempo
2,2,6,6-四甲基哌啶氧化物
Tempo 是一种经典的一氧化氮自由基,也 是一种线粒体 ROS 的选择性清除剂,可在催化循环中使超氧化物歧化。Tempo 可诱导 DNA 链断裂,并可用作将伯醇氧化为醛的有机催化剂。Tempo 具有诱变和抗氧化作用。 - GC39503 PROTAC FKBP Degrader-3 PROTAC FKBP Degrader-3 是一种包含 FKBP 配体结合基团,linker 和 VHL 结合基团的 PROTAC。PROTAC FKBP Degrader-3 是一种有效的 FKBP 降解剂。
- GC39500 PDK4-IN-1 hydrochloride PDK4-IN-1 hydrochloride 是一种蒽醌衍生物,也是一种有效的,口服活性的丙酮酸脱氢酶激酶 4 (PDK4) 抑制剂,IC50 值为 84 nM。PDK4-IN-1 hydrochloride 有效抑制细胞转化和细胞增殖并诱导细胞凋亡 (apoptosis)。PDK4-IN-1 hydrochloride 具有抗糖尿病,抗癌和抗过敏作用。
-
GC39489
GPNA hydrochloride
Γ-(P-硝基苯胺)-L-谷氨酸盐酸盐
GPNA (L-γ-Glutamyl-p-nitroanilide) is a potent and selective inhibitor of the glutamine (Gln) transporter ASCT2(SLC1A5) with Ki of 55 ?M. - GC39485 CK2/ERK8-IN-1 A dual inhibitor of CK2 and ERK8
- GC39483 BO-264 A TACC3 inhibitor
-
GC39450
Tea polyphenol
茶多酚
Tea polyphenols are chemical compounds such as flavanoids and tannins found naturally in tea. Several biological properties have been associated to tea polyphenols (TP), including antioxidant, anti-carcinogenic and antimicrobial activities. -
GC39430
Reslizumab
Sch 55700
Reslizumab (Sch 55700) 是靶向人白介素 5 (IL-5) 的人源化单克隆抗体,用于治疗嗜酸性粒细胞性哮喘。Reslizumab 可有效阻断 IL-5 的功能。Reslizumab 抑制 IL-5 依赖性细胞增殖,IC50 值约为 91.1pM。Reslizumab 对人 IL-5 具有高结合亲和力,在 Biacore 表面等离振子共振和动力学排斥分析中,KD 值分别为 109 pM 和 4.3 pM。 -
GC39428
Quinoclamine
灭藻醌
Quinoclamine 是一种萘醌衍生物,是一种 NF-κB 抑制剂。Quinoclamine 具有抗肿瘤活性。 -
GC39415
OR-1896
左西孟旦杂质
OR-1896 是 Levosimendan 的活性长寿代谢产物。OR-1896 是一种高选择性磷酸二酯酶 (PDE III) 抑制剂,是一种功能强大的血管扩张剂。OR-1896 可以打开 ATP 敏感的 K+ 通道,并具有 Ca2+ 致敏作用。OR-1896 可减轻心肌细胞的凋亡,心脏重塑和心肌炎症。 - GC39388 GW274150 phosphate GW274150 phosphate 是一种有效的,选择性的,口服活性的 NADPH 依赖型人一氧化氮合成酶 (iNOS) (Kd=40 nM) 和大鼠 iNOS 抑制剂,对人和大鼠 eNOS 和 nNOS 均显示较低效力。GW274150 phosphate 在急性肺损伤炎症模型中发挥保护作用。
- GC39382 FW1256 FW1256 是一种苯基类似物,也是一种缓释硫化氢 (H2S) 供体。FW1256 抑制 NF-κB 活性,并可诱导细胞凋亡 (apoptosis),并可用于癌症,炎症和心血管疾病的研究。
- GC39377 EB-3D EB-3D is a potent and selective inhibitor of choline kinase α (ChoKα) with IC50 of 1 μM for ChoKα1. EB-3D induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells.
-
GC39372
Desethyl chloroquine diphosphate
脱乙基氯喹二磷酸盐
Desethyl chloroquine diphosphate 是 Chloroquine 的主要去乙基代谢产物。Chloroquine 是一种自噬和 toll-like receptors (TLRs) 的抑制剂。Desethyl chloroquine diphosphate 具有抗疟原虫活性。 - GC39365 CPTH2 A HAT inhibitor
- GC39355 BTSA1 BTSA1 is a pharmacologically optimized BAX activator that binds with high affinity and specificity to the N-terminal activation site and induces conformational changes to BAX leading to BAX-mediated apoptosis. It effectively promotes apoptosis in leukemia cell lines and patient samples while sparing healthy cells.
-
GC39346
Benralizumab
MEDI-563; BIW-8405
Benralizumab (MEDI-563) 是一种白介素 5 受体 α (IL-5Rα) 定向的溶细胞单克隆抗体,通过增强抗体依赖性细胞介导的细胞毒性诱导嗜酸性粒细胞直接,快速和几乎完全耗尽。Benralizumab 可用于严重的嗜酸性哮喘。 -
GC39326
2-Iminobiotin hydrobromide
2-亚氨基生物素盐酸盐; Guanidinobiotin hydrobromide
2-Iminobiotin hydrobromide (Guanidinobiotin hydrobromide) 是一种生物素 (维生素 H 或 B7) 类似物。2-Iminobiotin hydrobromide 是一种可逆的 NO 合酶抑制剂,作用于小鼠 iNOS 和大鼠 n-cNOS,Ki 值分别为 21.8 和 37.5 μM。2-Iminobiotin hydrobromide 与低温环境可保护人类神经细胞免受缺氧诱导的细胞损伤。 -
GC39325
2,5-Dihydroxyacetophenone
2,5-二羟基苯乙酮; 2',5'-二羟基苯乙酮
2',5'-Dihydroxyacetophenone (DHAP, 2-Acetylhydroquinone, Quinacetophenone) is a mixture of dihydroxyacetophenone isomers is used in food flavouring. 2',5'-Dihydroxyacetophenone significantly inhibits NO production via the suppression of iNOS expression. 2',5'-Dihydroxyacetophenone significantly decreases levels of the pro-inflammatory cytokines TNF-α and IL-6 by blocking the ERK1/2 and NF-κB signaling pathways. -
GC39321
(Rac)-Myrislignan
ALPHA-[1-[2,6-二甲氧基-4-(2-丙烯-1-基)苯氧基]乙基]-4-羟
(Rac)-Myrislignan 是Myrislignan 的外消旋体。 Myrislignan 是从Myristica fragrans Houtt 分离得到的一种木酚素,具有抗炎活性。Myrislignan 通过抑制NF-kB信号通路的激活,减轻LPS诱导的小鼠巨噬细胞炎症反应。 - GC50611 NBC 6 NBC 6 是一种有效的、选择性的 NLRP3 炎性体抑制剂 (IC50= 574 nM),其作用独立于 Ca2+。
-
GC50569
NLRP3-IN-2
4-[2-(5-氯-2-甲氧基苯甲酰氨基)乙基]苯磺酰胺
An NLRP3 inflammasome inhibitor - GC50556 NBC 19 Potent NLRP3 inflammasome inhibitor
- GC50511 UCLA GP130 2 A humanin peptide mimetic
- GC50422 10-Cl-BBQ Potent aryl hydrocarbon receptor (AhR) agonist; orally bioavailable
- GC50374 TH 1020 An inhibitor of the TLR5-flagellin protein-protein interaction
-
GC50356
CL 075
2-丙基噻唑并[4,5-C]喹啉-4-胺,3M002
CL 075 (3M002) 是一种具有免疫调节特性的选择性 TLR8 激动剂。 - GC50350 TC JL 37 TC JL 37 是一种有效的、选择性的、可口服的 TYK2 抑制剂,Ki 为 1.6 nM。
- GC50342 CP 424174 An inhibitor of stimulus-coupled IL-1β post-translational processing
- GC50297 RS 09 A TLR4 agonist
-
GC50296
D9
D9 是一种有效的选择性硫氧还蛋白还原酶 (TrxR) 抑制剂,EC50 为 2.8 nM。 D9 具有在体外和体内抑制肿瘤增殖的能力。
- GC50292 c-Di-GMP sodium salt Endogenous STING and DDX41 agonist; activates STING-dependent signaling
-
GC50280
JX 06
NSC 402538
An irreversible PDHK inhibitor -
GC50253
PF 543 hydrochloride
Sphingosine Kinase 1 Inhibitor II hydrochloride
A potent inhibitor of SPHK1 - GC50243 NFAT inhibitor, Cell Permeable A cell-permeable form of NFAT inhibitor
- GC50242 RA 839 RA 839 是 Keap1 的非共价小分子结合剂,Kd 约为 6 μM,是 Nrf2 信号传导的选择性激活剂。
- GC50241 M62812 TLR-4 inhibitor
- GC50238 PMX 53c Negative control for PMX 53
-
GC50190
Fenretinide - d4
4-HPR-d4, 4-Hydroxy(phenyl)retinamide-d4, Retinoic Acid p-hydroxyphenylamide-d4
An internal standard for the quantification of fenretinide -
GC50176
PMX 53
3D53
PMX 53 (3D53) 是一种合成肽类,是一种有效且具有口服活性的补体 C5a 受体 (CD88) 拮抗剂,IC50 为 20 nM。